Web Results
First | Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next | Last
IMPLICATIONS FOR PATIENTS WITH LYMPHOMA AS A RESULT OF CMS ... (Search Map)
The BEXXAR® Therapeutic Regimen and the ZEVALIN® Therapeutic Regimen belong ... BEXXAR® Therapeutic Regimen, as approved by the FDA, consists of the following ...
Radioimmunotherapy for Non-Hodgkin's Lymphoma: Ibritumomab ... (Search Map)
A single course of treatment with Bexxar therapeutic regimen is considered medically necessary. ... The Bexxar therapeutic regimen is administered in two steps: the ...
Bexxar (Tositumomab) - Bexxar (Tositumomab) for Follicular ... (Search Map)
Bexxar (tositumomab) is a type of radioimmunotherapy drug that's used for follicular non ... It is usually administered in 2 steps as the "Bexxar therapeutic regimen. ...
New treatment rivals chemotherapy for lymphoma, U-M study ... (Search Map)
Patients with advanced-stage follicular lymphoma improved with the Bexxar therapeutic regimen.
Danielle Halstrom Laura Liotta GlaxoSmithKline Sam Brown Inc ... (Search Map)
The BEXXAR Therapeutic Regimen is now indicated for the treatment of patients with CD ... the BEXXAR Therapeutic Regimen was based on overall response rates in patients whose ...
GlaxoSmithKline - Press Archive - Corixa and GlaxoSmithKline ... (Search Map)
The Bexxar therapeutic regimen, which is given in four office visits ... The Bexxar therapeutic regimen has demonstrated independently confirmed, disease ...
Monoclonal Antibody Therapy: Bexxar® (Search Map)
Information on Bexxar - a monoclonal antibody chemotherapy for Non-Hodgkin's Lymphoma ... The BEXXAR therapeutic regimen was associated with a risk of hypothyroidism and human ...
ASH: "Bexxar" Regimen Induces Complete Response in Patients ... (Search Map)
ASH: "Bexxar" Regimen Induces Complete Response in Patients with ... Based on prior studies, the regimen was recently approved for the treatment of patients ...
Corporate Archive: Studies presented at ASH explore activity ... (Search Map)
Corporate Archive: GlaxoSmithKline Press Release: Studies presented at ASH explore activity of the Bexxar ® therapeutic regimen in difficult-to-treat lymphomas
Bexxar: Low Risk of Secondary MDS/AML - Cancer Network (Search Map)
Dr. Bennett noted that many durable long-term remissions have been reported in patients treated with the Bexxar therapeutic regimen (see article on page 13) ...
First | Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next | Last